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actions among biological macromolecules in their native environments. FRET analysis has also been successfully applied to
study the spatiotemporal regulation of various cellular processes using genetically encoded FRET-based biosensors. A variety
of procedures have been described for measuring FRET efficiency or the relative abundance of donor-acceptor complexes,
based on analysis of the donor fluorescence lifetime or the spectrally resolved fluorescence intensity. The latter methods are
preferable if one wants to not only quantify the apparent FRET efficiencies but also calculate donor-acceptor stoichiometry
and observe fast dynamic changes in the interactions among donor and acceptor molecules in live cells. This review focuses
on a comparison of the available intensity-based approaches used to measure FRET. We discuss their strengths and weak-
nesses in terms of FRET quantification, and provide several examples of biological applications.INTRODUCTIONThe spatiotemporal localization of molecular interactions
is of key importance for understanding the signaling
processes that coordinate cellular function. Typically,
although proteins vary in size by up to tens of nanometers,
the resolution of standard fluorescence microscopy is an
order of magnitude larger. Recent developments in superre-
solution microscopy have successfully overcome this
optical resolution limit for particular applications; however,
direct imaging of protein-protein interactions remains
elusive. Fo¨rster resonance energy transfer (FRET) is a phys-
ical process in which weak electronic coupling occurs
between two excitable molecules with 1), overlap of donor
emission and acceptor excitation spectra; 2), favorable
orientation of their transition dipole moments; and 3), close
proximity, leading to the quenching and sensitization of
donor and acceptor molecules, respectively (1–3). Over
the last few decades, various features of this physical
process have been exploited for the development of tools
to investigate molecular interactions that occur at distances
far below the diffraction-limited resolution.
Many previous reviews have discussed the main princi-
ples and biological applications of FRET (4–7); therefore,
in this work we provide a detailed overview of approaches
for quantifying and interpreting FRET. We briefly discuss
the advantages and disadvantages of methods that use
either fluorescence lifetimes or spectrally resolved intensity
measurements, with a particular focus on the various inten-
sity-based approaches. We compare intensity-based FRET
methods in terms of the required assumptions, limiting
constraints, and the experimental work flow, including
reference, calibration, and sample measurements. Finally,Submitted March 27, 2012, and accepted for publication September 21,
2012.
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0006-3495/12/11/1821/7 $2.00we provide several examples of the successful applica-
tion of spectral FRET methods to investigate biological
questions.APPARENT VERSUS CHARACTERISTIC FRET
EFFICIENCY
Although FRET efficiency is clearly defined as
E ¼ kETP
k
(1)
where kET is the energy transfer rate constant and
P
k sums
all depletion rates of the donor excited state, the meaning of
FRET efficiency can vary considerably depending on the
scale of one’s perspective. Macroscopically, any increase
in donor quenching and sensitized emission from a sample
can be interpreted as an increase in FRET efficiency. If
each donor within the macroscopic ensemble is examined
individually, the same change can be interpreted not as
a change in E or as a change in the fraction of donors
that participate in FRET complexes, while the FRET effi-
ciency E of the individual donor-acceptor FRET complexes
remains constant. In the following, we distinguish between
these situations by defining the characteristic FRET effi-
ciency according to Eq. 1 (8), and the apparent FRET effi-
ciency as the efficiency measured from the macroscopic
point of view. The apparent FRET efficiency can be defined
as the average of all characteristic FRET efficiencies present
in a sample weighed by the fraction of the relevant fluoro-
phores. In a sample with partial interaction of donor- and
acceptor-labeled molecules, two apparent FRET efficiencies
can be measured. One is the characteristic efficiency of
interaction scaled by the fractional occupancies of the
donor, fD, and the other is scaled by the fractional occupancy
of the acceptor, fA, given ashttp://dx.doi.org/10.1016/j.bpj.2012.09.031
1822 Zeug et al.EfD ¼ E½DA½Dt and EfA ¼
E½DA
½At (2)
respectively, where ½DA is the concentration of donor-
acceptor FRET complexes and ½Dt and ½At are the total
donor and acceptor concentrations, respectively. We will
show that either EfD or EfA can be measured depending
on the specific form of the analysis. This distinction is
important for biological applications in which interactions
among donor and acceptor molecules are of central interest.
In such cases the fractional occupancies, rather than the
magnitude of E, will provide information about the degree
of interaction.FLUORESCENCE-LIFETIME APPROACHES
When the criteria for FRET are fulfilled, an additional
depletion pathway of the excited donor state becomes avail-
able. This reduces the donor fluorescence lifetime and
allows the energy transfer efficiency to be determined as
E ¼ 1 tDA=tD, where tDA and tD are the fluorescence
lifetimes of the quenched and free donor, respectively.
These quantities can be measured directly by time-corre-
lated single-photon counting (TCSPC), in which fluores-
cence decay histograms are compiled from fluorescence
photon arrival times after pulsed excitation. The major
advantage of this strategy is that the measurements them-
selves do not require extensive calibration. Furthermore,
these measurements are relatively robust, lacking many of
the artifacts that plague other approaches. Because TCSPC
probes individual donor fluorescence events in serial, this
method has the ability to provide information about the
discrete FRET states as well as the donor fractional
occupancy by fD ¼ ADA=ðADA þ ADÞ, where ADA and AD
are the amplitudes of the individual decay components.
However, it is not possible to obtain fA by fluorescence-life-
time measurements, because the acceptor fluorescence is
usually not considered. Another major drawback of this
method is the large amount of photons that must be
collected to build fluorescence-decay histograms, which is
necessary to fit data with the reasonable accuracy. This
is particularly problematic when one attempts to build
histograms from which separate decay components can be
resolved. Accordingly, changes in FRET can only be
measured with relatively low spatiotemporal resolution.
As a faster alternative to TCSPC, one can quantify the fluo-
rescence lifetime in the frequency domain by measuring
the phase shift and amplitude between the modulation of
excitation and emission. Although the temporal resolution
of this approach is much higher, only a fraction of the
emitted photons are used for evaluation. On the other
hand, because the signal/noise ratio of all fluorescence
measurements is ultimately limited by photobleaching,
efficient photon use is of paramount concern for FRETBiophysical Journal 103(9) 1821–1827quantification. Additionally, it is difficult to distinguish
multiple fluorescence lifetimes in the frequency-domain
method using one modulation frequency, although the polar
plot approach (9–11) tries to overcome this problem. With
rare exceptions (12,13), most applications of fluorescence-
lifetime measurements do not separate exponential compo-
nents, and thus only the mean lifetime, which cannot be
used to quantify E or EfD, is measured. On the other hand,
fluorescence-lifetime FRET approaches allow the use of
dark acceptors (14,15), which cannot be applied by the
most intensity-based approaches.INTENSITY-BASED FRET APPROACHES
Alternatives to fluorescence-lifetime imaging microscopy
(FLIM) include intensity-based approaches that can differ-
entially exploit the complete spectral range. The ability to
distinguish between donor and acceptor fluorescence
minimizes the waste of photons, and the equipment re-
quired for intensity-based approaches is standard in
most laboratories. The fluorescence emission from donor
and acceptor fluorophores undergoing FRET is the super-
position of five quantities: the donor fluorescence from 1),
free donor ½D and 2), donor acceptor complexes ½DA
scaled by (1  E); and the acceptor fluorescence from
3), free acceptor ½A; 4), directly excited acceptor in donor
acceptor complexes; and 5), acceptor emission resulting
from energy transfer from a donor within a donor-
acceptor complex:
FiðlÞ ¼ IihiðlÞεiDQDeDðlÞ½D þ εiDQDeDðlÞ½DAð1 EÞ
þ εiAQAeAðlÞ½A þ εiAQAeAðlÞ½DA
þ εiDQAeAðlÞ½DAE

(3)
where the subscripts D and A refer to donor and acceptor,
respectively, and the superscript i refers to the i-th excita-
tion wavelength. FiðlÞ is the measured fluorescence spec-
trum, Ii is the excitation intensity, hiðlÞ is the device
transfer function, εiD;A are the extinction coefficients, QD;A
are the fluorescence quantum yields, and eD;AðlÞ are the
unit area normalized fluorescence spectra. Due to this
complexity, it becomes apparent that the direct deter-
mination of FRET efficiency from spectrally resolved
intensity-based measurements is not possible without
additional information. Accordingly, unlike fluorescence-
lifetime measurements, most spectral approaches make
certain assumptions (e.g., acceptor photobleaching (APB)
requires the fluorophores to be fixed in space, and linear
unmixing FRET (lux-FRET) relies on fluorescence
quantum yields of both donor and acceptor) and require
reference and calibration measurements for a quantitative
interpretation of the results.
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The most common intensity-based FRET approach, APB,
measures the donor emission intensity in the presence and
absence of the acceptor. This is achieved by measuring the
donor fluorescence intensity before and after selective
bleaching of the acceptor (16–18). Generally, this method
requires irreversible bleaching, which limits it to a single
measurement, and is commonly applied to fixed samples
to prevent diffusion artifacts. However, the development
of photoreversible organic dyes and fluorescent proteins
has raised the possibility of using this approach for dynamic
measurements in live cells (19,20).
FRET quantification with this method is similar to that
achieved with fluorescence-lifetime methods, but relies on
intensity information about the donor before (FDA) and
after (FDt ) APB, rather than fluorescence-lifetime decays.
Moreover, the computed quantity EfD ¼ 1 FDA=FDt is
sensitive to errors caused by reabsorption, nonuniformity
in the illumination/bleaching beams, and aberration in the
excitation and emission beam path. Further corrections
must be applied to compensate for incomplete acceptor
bleaching and bleaching artifacts of the donor during
acquisition. Because this technique is based on the donor
emission only, the user receives no information about EfA.
The advantage of this strategy, however, lies in its
simplicity. APB measurements do not require any special-
ized equipment, except for a spatially defined bleaching
capability, and thus can be performed on a wide range of
instruments. In most cases the donor emission spectra are
well separated from those of the acceptor, and thus no un-
mixing is required. A change in donor fluorescence intensity
alone provides very clear evidence of FRET, and EfD can be
calculated through a relatively simple analysis.Semiquantitative sensitized emission
FRET can also be identified by measuring the acceptor
emission resulting from donor excitation. In practice,
however, an acceptor emission channel is often polluted
by bleed-through of the donor emission. Youvan et al. (21)
introduced a filter-based method to extract acceptor fluores-
cence intensity changes while correcting for donor direct
acceptor excitation and donor bleed-through (21):
nF ¼ FexD;emA  aFexA;emA  bFexD;emD (4)
For this method, three measurements are required. First, at
an excitation wavelength that directly excites the donor,
the emission is measured in the acceptor and donor chan-
nels, FexD;emA and FexD;emD , respectively. Next, fluorescence
is measured in the acceptor channel FexA;emA at an excitation
wavelength that selectively excites the acceptor. The
amount of donor bleed-through into the acceptor channel
is determined by a donor-only measurement, which pro-
vides the calibration constant b ¼ FexD;emAD =FexD;emDD . In anacceptor-only measurement, the extent to which the short-
wavelength excitation directly excites the acceptor is
determined relative to the excitation at the longer wave-
length. This results in the constant a ¼ FexD;emAA =FexA;emAA . It
should be noted that although the donor bleed-though into
the acceptor channel is considered and corrected for, any
acceptor bleed-through into the donor channel is neglected.
Methods that use these three measurements are collectively
known as three-cube methods, reflecting the need to use
three different filter cubes to perform the measurements.
Both of the calibration constants, a and b, are fluorophore
and system specific, and may vary with the performance
of the device. Thus, occasionally it may be necessary
to repeat the donor-only and acceptor-only reference
measurements.
It is also notable that the nF, as provided by Eq. 4, does not
represent a characteristic or even apparent FRET efficiency,
and instead provides a value that varies with FRET (22).
Specifically, this FRET index varies with the donor and
acceptor concentration. Several studies have attempted to
address this problem by scaling nF by various, somewhat
arbitrary combinations of the donor and acceptor signals.
The most popular forms are FRETN ¼ nF=ðFexA;emA
FexD;emDÞ (23) and NFRET ¼ nF=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
FexA;emA  FexD;emDp (24).
Quantitative correlation of such FRET indices with physical
processes or with the terms of Eq. 3 is unclear, as even the
most extensively corrected approach,NFRET , has been shown
to be nonlinear with respect to changes in E and fractional
occupancies (25). Unfortunately, these strategies have been
adopted by device manufacturers and are often found in
microscope acquisition and image-processing software.
Consequently, these methods continue to be widely used,
even in the presence of several better-defined alternatives.FRET stoichiometry—three-cube quantification
A quantitative solution to determine the apparent FRET
efficiency from measurements of acceptor intensity was
proposed by Lakowicz (8) in the form of
EfA ¼ ε
exD
A
ε
exD
D

FexD;emADA  FexD;emAA
FexD;emAA

(5)
where εexDD and ε
exD
A are the extinction coefficients of the
donor and acceptor, respectively, at donor excitation. It
should be noted that the fractional occupancy of acceptor
which we denote as fA here is called fD in (8). This equation
cannot be directly applied as written, and can only be used
in the hypothetical situation in which the acceptor in
a FRET sample can be measured in the absence of the donor.
More recently, Hoppe and colleagues (25) applied correc-
tions for donor bleed-through and excitation cross talk to
Eq. 5 to quantify apparent FRET efficiency with sensitized
emission measurements using a three-cube microscope
setup. The resulting equation,Biophysical Journal 103(9) 1821–1827
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aFexA;emAA
(6)
where g ¼ εexDA =εexDD , still requires information about the
relative excitability of the donor and acceptor at the donor
excitation wavelength. By applying Eq. 6 to a referencemea-
surement of a donor-acceptor tandem construct with known
characteristic FRET efficiency, as measured from fluores-
cence-lifetime measurements, one can determine g. Hoppe
et al. (25) further extended this approach by taking into
account the donor quenching due to FRET, and were able
to calculate the donor-dependent apparent FRET efficiency:
EfD ¼ 1 F
exD;emD
nFðx=gÞ þ FexD ;emD (7)
as well as the donor acceptor ratio:
Rth
½At
½Dt ¼

x
g2

aFexA;emA
nFðx=gÞ þ FexD;emD (8)
To calculate EfD and R
t, one must determine the constant x,
which contains information about the donor and acceptor
quantum efficiencies and the device detection efficiency,
in a manner similar to that used for g, by applying reference
measurements of a known FRET efficiency construct and
solving Eq. 7.
Thus, in addition to quantifying a and b from donor-only
and acceptor-only reference measurements in a manner
similar to that described by Youvan et al. (21), one must
perform an additional reference measurement of a donor-
acceptor tandem construct with known FRET efficiency to
determine g and x. Furthermore, the excitation wavelengths
and emission channels are constrained as in the calculation
of nF, such that exA does not excite the donor and no
acceptor emission occurs in the donor channel.
FRET stoichiometry has been packaged into an easily
implemented and clearly documented ImageJ plug-in.
However, although only a single additional reference mea-
surement is required to apply the FRET stoichiometry
approach, the nonquantitative, nF-like approaches continue
to be used more frequently for a variety of biological
applications.Spectral RET
In 2005, Thaler et al. (26) presented a quantitative FRET
approach that uses spectral imaging detectors. In that work,
the fluorescence signal from a FRET sample was discussed
as a superposition of three quantities: 1), the quenched donor
emission; 2), the acceptor emission from direct excitation;
and 3), the acceptor emission sensitized through FRET:
Fcomplex ¼ d$ð1 EÞ$FD þ a$FA þ d$E$QA
QD
$kðlÞ$FA (9)Biophysical Journal 103(9) 1821–1827This equation is similar to Eq. 3. However, FD and FA are
the unit emission spectra measured from a fixed amount
of fluorophore under defined conditions, and thus contain
the information IihiðlÞεiD=AQD=AeD=AðlÞ. d and a are frac-
tions of the donor and acceptor unit concentration. The
transfer factor ki ¼ R FDdl=R FAdl, measured as the ratio
of fluorescence intensities for equal concentrations of donor
and acceptor, represents the ratio of the fluorophores’ photo-
physical properties, εiDQD=ε
i
AQA. To find a solution for d, a,
and E, two spectral datasets of the donor and acceptor refer-
ence and the FRET sample acquired at two different excita-
tion wavelengths are required. The rephrased equations in
(26) are then
d ¼ dþ QD
QA
$
Da
Dk
(10)
k2$a1  k1$a2
a ¼
Dk
(11)
1
E ¼
1þ d$QA=QD$Dk=Da (12)
where d and ai are the apparent concentrations obtained
from linear unmixing, Dk ¼ k2  k1 and Da ¼ a2  a1.
Unfortunately, the spectral RET approach requires refer-
ence samples of known concentration (i.e., purified fluores-
cent proteins). Furthermore, variation in excitation power,
wavelength, bandwidth, and pulse width prevents the use
of predetermined references. In addition, spectral RET
does not explicitly consider free donor and acceptors in
the sample; rather, it states that in the presence of free donor
and free acceptor, E becomes a certain weighted average E.
Also, the explicit relation of spectral RET to EfD and EfA
remains unclear.Lux-FRET
Inspection of Eq. 3 indicates that the measured spectrum
FiðlÞ from a sample (or pixel of an image) that contains a
mixture of unpaired acceptors at concentration ½A, unpaired
donors ½D, and donor-acceptor complexes ½DA is a linear
superposition of terms (the first row in Eq. 3) that have
the emission properties of the donor and others that have
the emission properties of the acceptor. By rearranging
Eq. 3, we obtain
FiðlÞ ¼ IihiðlÞ

ε
i
DQDeDðlÞð½Dt þ ½DAð1 EÞÞ
þ εiAQAeAðlÞ

½At þ ε
i
D
ε
i
A
E½DA
 (13)
This suggests a spectral separation either by linear unmixing
or by fitting with the sum of the scaled donor and acceptor
Quantitative Intensity-Based FRET 1825reference spectra, FiðlÞ ¼ di$Fi;refD ðlÞ þ ai$Fi;refA ðlÞ. These
two spectra, Fi;refD ðlÞ and Fi;refA ðlÞ, have to be obtained by
two reference measurements on samples that contain donor
and acceptor only at concentration ½Dref  and ½Aref , respec-
tively. Normalizing the components of the fit with respect to
these references cancels out hiðlÞ and eD;AðlÞ, and leaves
only the ratios QD=QA and ε
i
D=ε
i
A as parameters that have
to be obtained from the literature or measured separately.
We call the normalized fitting coefficients the apparent
concentrations of donor ðdiÞ and acceptor ðaiÞ, and arrive at
di ¼ ð½D
t þ ½DAð1 EÞÞ
½Dref  (14)

ε
i

ai ¼
½At þ D
ε
i
A
E½DA
½Aref  (15)
Furthermore, a consideration of the spectral parameters of
the reference measurements yields
rex;ih
ε
i
D
ε
i
A
$
½Dref 
½Aref  ¼
Fi;refD ðlÞ
eDðlÞ $
eAðlÞ
Fi;refA ðlÞ
$
QA
QD
(16)
where rex;i are the ratios of excitation strengths (donor/
acceptor) at excitation wavelengths i.
Substituting Eq. 16 into Eqs. 14 and 15, and considering
two excitation wavelengths results in four equations for
three unknowns ð½Dt, ½At, and E½DAÞ. Disregarding d2,
which represents the excitation of donor at the second
(long) wavelength, which is usually very small, leaves three
unknowns to be calculated, resulting in
EfDhE
½DA
½Dt ¼
Da
Drd1 þ Da (17)
½DA Da
EfAhE ½At ¼ RTCa2rex;1  a1rex;2 (18)
Here RTC ¼ ½Dref =½Aref  obtained from tandem construct
and Da ¼ a2  a1 and Dr ¼ rex;2  rex;1. Similarly, Eqs.
14 and 15 can be solved for ½Dt and ½At in terms of the
respective reference concentrations (27).
Lux-FRET corrects for bleed-through, cross talk, and
unpaired fluorophores in two well-separated steps: First, it
takes bleed-through into account in a rigorous way by sepa-
rating the spectral components. Thus, it does not need to
restrict data acquisition to well-separated spectral channels,
and instead uses photons from the whole spectrum for the
fitting process, resulting in better efficiency of photon usage
(26). It should be also noted that the equivalent of the three-
cube measurement is readily performed using two filter
cubes for two excitations, with a beam splitter that separatesthe emission into two channels. Linear unmixing in this case
is reduced to solving two linear equations with two
unknowns (see Appendix 1 in Wlodarczyk et al. (27)). In
a second step, by solving Eqs. 14 and 15, the method takes
the contributions of unpaired donors and acceptors rigor-
ously into account. For cases in which one can assume
a time-invariant and uniform donor/acceptor ratio (as in
the case of tandem construct sensors), one can employ
simplified imaging modes to measure lux-FRET (1). For
example, after an initial spectrally resolved dual-excitation
calibration, the user can perform repetitive single-excitation
wavelength measurements to quantify EfD at high temporal
resolution.
Practically, lux-FRET can be performed on all devices that
offer spectral resolution, such as spectrofluorometers and
spectral detectors in imaging systems (Zeiss 510 META,
Zeiss 710/780, and Nikon A1), as well as on filter-based
systems.APPLICATIONS OF QUANTITATIVE, INTENSITY-
BASED FRET METHODS
The aforementioned intensity-based FRET approaches have
been extensively used to analyze different aspects of
protein-protein interactions in live cells. In addition, spec-
tral FRET analysis has been successfully applied to study
the spatiotemporal regulation of various cellular processes
using genetically encoded FRET-based biosensors. The
main advantage of these approaches in biological applica-
tions is that they allow one to not only detect and quantify
apparent FRET efficiencies but also to calculate donor-
acceptor stoichiometry and even relative interaction affinity.
Moreover, the combination of spectral FRET approaches
with microscopy provides the unique possibility to monitor
macromolecular interactions in live cells with high resolu-
tion in real time.
For example, FRET stoichiometry (25) has been used
in a couple of studies to analyze the molecular mechanism
of phagocytosis in macrophages, particularly the contribu-
tions of small GTPases (e.g., Cdc42, Rac1, Rac2, Arf1,
and Arf6) to this process. Analysis of the activation
dynamics of endogenous small GTPases by FRET revealed
that their activity was mostly restricted to phagocytic
cups (28). Moreover, FRET analysis indicated distinct
patterns of GTPase activation during phagocytosis: activa-
tion of Cdc42 occurred at the tip of pseudopodia, whereas
Rac1 and Rac2 were preferentially active in phagocytic
cups during phagosome closure. FRET stoichiometry also
showed that the small GTPases Arf1 and Arf6 possess a
different activation profile (i.e., activated ARF6 was con-
centrated at the tip of pseudopodia, whereas activated
Arf1 was distributed throughout the forming phagosome)
and coordinate different functions of the phagosome form-
ing in a PI3K-dependent manner (29). In a subsequent study
using similar experimental strategies, Beemiller et al. (30)Biophysical Journal 103(9) 1821–1827
1826 Zeug et al.demonstrated that the interdependent activities of PI3K
and Cdc42 are critically involved in organizing the actin
dynamics in the phagocytic cup. In parallel, FRET stoichi-
ometry was extended to three-dimensional FRET recon-
struction microscopy, which allows for high-resolution
four-dimensional (x,y,z,t) imaging of molecular interactions
(31). This novel approach was then used to elucidate spatio-
temporal details of the signaling framework involved in the
formation of macropinosomes in macrophages (32).
Another very broad field of applications for intensity-
based FRET approaches is the analysis of protein oligomer-
ization and clustering. For example, Meyer and colleagues
(33) improved the sensitized acceptor emission FRET
approach and investigated the oligomerization state of the
neurokinin-1 receptor (NK1R). They demonstrated that
functional NK1Rs exist as monomers at the physiological
expression level. The same approach was used to analyze
the clustering of different heterotrimeric G-proteins in
microdomains (34). This study revealed that G-proteins
belonging to the Gi and Gq families show activation-specific
microdomain localization, which may be responsible for
their specific interaction with effectors. Another method of
choice for analyzing protein-protein interaction is lux-
FRET (27). As discussed above, this approach allows one
to calculate and visualize (Fig. 1) the apparent FRET effi-
ciencies for donors, EfD, and acceptors, EfA, over a wide
range of donor molar fractions, xD ðxD ¼ ½Dt=ð½Dtþ
½AtÞÞ. Lux-FRET was successfully applied to demonstrateFIGURE 1 Heterodimerization of 5-HT1A and 5-HT7 receptors investi-
gated by lux-FRET. 5-HT7-CFP (donor) and 5-HT1A-YFP (acceptor) recep-
tors were coexpressed in neuroblastoma N1E-115 cells. Images of apparent
FRET efficiency EfD were created according to the two-excitation lux-
FRET method after confocal microscopy. Size bar: 5 mm. Reproduced
from Renner et al. (37) with permission from the Journal of Cell Science.
Biophysical Journal 103(9) 1821–1827specific homo-oligomerization of serotonin 5-HT1A re-
ceptor in live cells (35,36). Using lux-FRET, we have also
shown that the 5-HT1A receptor can form heterodimers
with 5-HT7 receptors (Fig. 1). More importantly, by com-
bining lux-FRET with an appropriate dimerization model,
we were able to calculate the relative dissociation constants
for hetero- and homodimers, which allowed us for the
first time, to our knowledge, to compare the relative concen-
trations of homo- and heterodimers, as well as the corre-
sponding monomers, under physiological conditions (37).
Because lux-FRET analysis also allows one to estimate
the fraction of molecules that participate in complexes,
this approach was used to verify the role of transmembrane
domains TM4/TM5 as an interaction interface in 5-HT1A
receptor dimers (38). In addition, lux-FRET was applied
to verify homodimerization of the Src Homology 3 domain
of the Ca2þ channel b-subunits (39), as well as to demon-
strate a specific interaction between the survival motor neu-
ron protein and profilin2a (40).
The above-mentioned applications clearly demonstrate
that FRET approaches that deliver well-defined parameters
should be selected depending on the given question and
experimental conditions. There is no universal approach
that can be applied to all experimental situations, and each
described technique has specific advantages and disadvan-
tages compared with the others. If the fluorescence quantum
yields of the individual fluorophores are known, the lux-
FRET approach may provide the best quantitative results
because it is sensitive and requires only minimal calibration
efforts. However, if the fluorescence quantum yields are not
known, it is advisable to apply either the FRET stoichiom-
etry (if reference samples are available) or spectral RET
(if the appropriate equipment is available). On the other
hand, if the donor fluorescence decay is monoexponential,
fluorescence-lifetime FRET may be a potential alternative
to the spectral approaches because it can provide both
E and EfD. The selection and design of the particular
FRET approach should be tailored according to the specific
application.
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